Tuesday, 17 September 2024, 8:46 PM
Site: EUPATI Open Classroom
Course: EUPATI Open Classroom (EUPATI Open Classroom)
Glossary: Glossary
E
European Network of Paediatric Research at the European Medicines AgencyEuropean Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) http://www.ema.europa.eu/ema/index.jsp?curl=pages/partners_and_networks/general/general_content_000303.jsp" |
European Paediatric Formulation InitiativeEuropean Paediatric Formulation Initiative (EuPFI) http://www.eupfi.org/" |
European Patent OfficeEuropean Patent Office |
European Patients’ Academy on Therapeutic InnovationEuropean Patients’ Academy on Therapeutic Innovation (EUPATI) https://eupati.eu/" |
European Public Assessment ReportA European Public Assessment Report (EPAR) is an assessment produced for all medicines where marketing authorisation is sought through the centralised procedure at the European Medicines Agency (EMA). It is a series of documents, and includes:
EPARs are published on the EMA’s website once the European Commission has issued a decision regarding a marketing authorisation. |
European UnionEuropean Union (EU) http://europa.eu" |
European Union Clinical Trials RegisterEuropean Union Clinical Trials Register (EUCTR) https://www.clinicaltrialsregister.eu/ctr-search/search" |
European Union Committee of Experts on Rare DiseasesEuropean Union Committee of Experts on Rare Diseases |
Evidence-based MedicineEvidence-based medicine (EBM) applies the scientific method to medical practice, using techniques from science, engineering, and statistics - such as the meta-analysis of scientific literature, benefit-risk analysis, and randomised controlled trials. One of the goals of evidence-based medicine is that healthcare professionals should make 'conscientious, explicit, and judicious use of current best evidence' in their everyday practice. |
Excerpta Medica DatabaseExcerpta Medica Database (EMBASE) https://www.embase.com" |